In our report, we confirmed in a homogeneous population of non-chemorefractory patients, the association between leptin-mediated overt metabolic disorders, blood pro-inflammatory cytokine profile and responsiveness to maintenance IO. This evidence concerns the gene LEP and Other metabolic disease.